MK-0752

DB12852InvestigationalSmall molecule

Mk 0752 is under investigation in clinical trial NCT00572182 (MK0752 in Treating Young Patients With Recurrent or Refractory CNS Cancer).

Chemical structure of MK-0752
Formula / weight
C21H21ClF2O4S · 442.9 g/mol (avg)
Code names
MK-0752

Resolves to

Compound
UNII9JD9B4S53TCAS471905-41-6PubChem9803433
Structure
InChIKeyXCGJIFAKUZNNOR-QCKZDCLWSA-NSMILESOC(=O)CC[C@H]1CC[C@@](CC1)(C1=C(F)C=CC(F)=C1)S(=O)(=O)C1=CC=C(Cl)C=C1
Targets
P49768PSEN1Q92542NCSTNQ9NZ42PSENENQ8WW43APH1BQ96BI3APH1A

What you can answer from here — as of January 29, 2025

5Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
9Clinical trialsPhase, status and sponsor resolved per trial
Sign in
6+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with MK-0752, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In